Distinct in vitro interaction pattern of dopamine receptor subtypes with adaptor proteins involved in post-endocytotic receptor targeting

FEBS Letters

Volumn 556, Issue 1-3, 2004, Pages 276-280

  Heydorn, Arne ^a   Søndergaard, Birgitte P ^a   Hadrup, Niels ^a   Holst, Birgitte ^a   Haft, Carol Renfrew ^b   Schwartz, Thue W ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Dopamine receptor; Ezrin radixin moesin binding phosphoprotein 50; N Ethylmaleimide sensitive factor; Protein sorting; Sorting nexin 1

Indexed keywords

ADAPTOR PROTEIN; BINDING PROTEIN; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR; EZRIN RADIXIN MOESIN BINDING PHOSPHOPROTEIN 50; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; N ETHYLMALEIMIDE SENSITIVE FACTOR; PHOSPHOPROTEIN; PROTEIN; RECEPTOR SUBTYPE; SORTING NEXIN 1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CONTROLLED STUDY; ENDOCYTOSIS; IN VITRO STUDY; LYSOSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RECEPTOR BINDING;

EID: 0346725011     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(03)01431-5     Document Type: Article

References (21)

1. Schwartz, T.W. and Holst, B. (2003) in: Textbook of Receptor Pharmacology (Foreman, J.C. and Johansen, T., Eds.), CRC Press, Boca Raton, FL.
2. Missale C., Nash S.R., Robinson S.W., Jaber M., Caron M.G. Physiol. Rev. 78:1998;189-225.
3. Milligan G., White J.H. Trends Pharmacol. Sci. 22:2001;513-518.
4. Brady A.E., Limbird L.E. Cell. Signal. 14:2002;297-309.
5. Cao T.T., Deacon H.W., Reczek D., Bretscher A., von Zastrow M. Nature. 401:1999;286-290.
6. Cong M., Perry S.J., Hu L.A., Hanson P.I., Claing A., Lefkowitz R.J. J. Biol. Chem. 276:2001;45145-45152.
7. Wang Y., Zhou Y., Szabo K., Haft C.R., Trejo J. Mol. Biol. Cell. 13:2002;1965-1976.
8. Zhang J., Ferguson S.S., Barak L.S., Aber M.J., Giros B., Lefkowitz R.J., Caron M.G. Recept. Channels. 5:1997;193-199.
9. Iwata K., Ito K., Fukuzaki A., Inaki K., Haga T. Eur. J. Biochem. 263:1999;596-602.
10. Vickery R.G., von Zastrow M. J. Cell Biol. 144:1999;31-43.
11. Kim K.M., Valenzano K.J., Robinson S.R., Yao W.D., Barak L.S., Caron M.G. J. Biol. Chem. 276:2001;37409-37414.
12. Oak J.N., Lavine N., Van Tol H.H. Mol. Pharmacol. 60:2001;92-103.
13. Li M., Bermak J.C., Wang Z.W., Zhou Q.Y. Mol. Pharmacol. 57:2000;446-452.
14. Li M., Li C., Weingarten P., Bunzow J.R., Grandy D.K., Zhou Q.Y. Biochem. Pharmacol. 63:2002;859-863.
15. Smith F.D., Oxford G.S., Milgram S.L. J. Biol. Chem. 274:1999;19894- 19900.
16. Bermak J.C., Li M., Bullock C., Zhou Q.Y. Nat. Cell Biol. 3:2001;492-498.
17. Kim O.J., Ariano M.A., Lazzarini R.A., Levine M.S., Sibley D.R. J. Neurosci. 22:2002;5920-5930.
18. Smiley J.F., Levey A.I., Ciliax B.J., Goldman-Rakic P.S. Proc. Natl. Acad. Sci. USA. 91:1994;5720-5724.
19. Bergson C., Mrzljak L., Smiley J.F., Pappy M., Levenson R., Goldman-Rakic P.S. J. Neurosci. 15:1995;7821-7836.
20. Mason J.N., Kozell L.B., Neve K.A. Mol. Pharmacol. 61:2002;806-816.
21. Whistler J.L., Enquist J., Marley A., Fong J., Gladher F., Tsuruda P., Murray S.R., von Zastrow M. Science. 297:2002;615-620.